For: | Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol 2023; 29(37): 5292-5304 [PMID: 37899787 DOI: 10.3748/wjg.v29.i37.5292] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i37/5292.htm |
Number | Citing Articles |
1 |
Vasiliy I Reshetnyak, Igor V Maev. Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. World Journal of Experimental Medicine 2025; 15(1): 101771 doi: 10.5493/wjem.v15.i1.101771
|
2 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(719) |
Core Tip(691) |
Full Article(HTML)(3663)
|
Full Article with Cover (PDF)-1825K(209)
|
Full Article (Word)-130K(37)
|
Audio-14227K(22)
|
Peer-Review Report-222K(86)
|
Answering Reviewers-194K(67)
|
Full Article (PDF)-407K(195)
|
Full Article (XML)-119K(91)
|
Times Cited (0)
|
Total Visits (11008)
|
Open
|
3 |
Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guocai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng. Advances, challenges and future applications of liver organoids in experimental regenerative medicine. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1521851
|
4 |
Filippo Gabrielli, Eleonora Crepaldi, Alessia Cavicchioli, Marco Rivi, Arianna Carmen Costanzo, Carmela Cursaro, Pietro Andreone. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments. Biomolecules 2024; 14(10): 1227 doi: 10.3390/biom14101227
|
5 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitis. Exploration of Immunology 2024; : 624 doi: 10.37349/ei.2024.00163
|
6 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. An Integrated Pathogenetic Model of Primary Biliary Cholangitis. Livers 2025; 5(2): 15 doi: 10.3390/livers5020015
|